Bio-Rad Laboratories, Inc.
BIO- Exchange
- NYSE
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000012208
No open-market purchases or sales by Bio-Rad Laboratories, Inc. insiders were filed in the last 90 days; 399 institutions reported holding it in 13F filings for Q2 2026, worth $5.70B in total; no superinvestor holds it.
Other share classesBIO.B
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Bio-Rad Laboratories, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Bio-Rad Laboratories, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Allison Schwartz | Director | 1,734 | Sep 9, 2026 | 2 |
| Barry James | EVP, President, LSG | 2,025 | Sep 9, 2026 | 3 |
| Evran Sedat | EVP, Global Supply Chain | 3,603 | Sep 9, 2026 | 2 |
| Engelhardt Eva Anette | EVP, President, CDG | 1,828 | Sep 9, 2026 | 3 |
| DiVincenzo Jonathan P. | President & COO | 1,963 | Sep 9, 2026 | 2 |
| Enloe Courtney C | EVP, General Counsel & Sec | 1,652 | Sep 9, 2026 | 2 |
| Mehta Rajat | EVP, GBL Commercial Operations | 1,232 | Sep 9, 2026 | 1 |
| Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | 4,151 | Sep 9, 2026 | 2 |
| Schwartz Norman D | Chairman & CEO | 449,019 | Sep 9, 2026 | 2 |
| Edwards Jeffrey L | Director | 715 | Apr 23, 2026 | 1 |
| Hinckley Gregory K | Director | 1,215 | Apr 23, 2026 | 1 |
| Pinkston Arnold A | Director | 715 | Apr 23, 2026 | 1 |
| Pei Melinda Litherland | Director | 715 | Apr 23, 2026 | 1 |
| Corey Colleen | EVP, Global Human Resources | 19,550 | Sep 9, 2025 | 0 |
| Crowley Michael | EVP, GBL Commercial Operations | 8,171 | Mar 18, 2025 | 0 |
| Last Andrew J. | EVP, Chief Operating Officer | 7,559 | Sep 10, 2024 | 0 |
| Schwartz Steven D | 10% Owner | 13,006Indirect | Aug 28, 2024 | 0 |
| Schwartz Alice N | 10% Owner, Other: Director Emeritus | 437,510Indirect | Aug 28, 2024 | 0 |
| Ernst Timothy S | EVP, General Counsel & Sec | 3,397 | Mar 12, 2024 | 0 |
| May Simon | EVP, President, LSG | 3,105 | Mar 12, 2024 | 0 |
| Wright Dara | EVP, President, CDG | 1,827 | Dec 19, 2023 | 0 |
| Daskal Ilan | EVP, Chief Financial Officer | 2,486 | Sep 6, 2023 | 0 |
| Ramalingam Ajit | SVP, Chief Accounting Officer | 403 | Sep 6, 2023 | 0 |
| Dahowski Diane | EVP, Global Supply Chain | 11,880 | Sep 6, 2023 | 0 |
| Tumolo Annette | Executive Vice President | 4,593 | Nov 15, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 (view filing) | May 11 | 2 days | Engelhardt Eva AnetteEVP, President, CDG | SSaleBio-Rad A Common Stock | −550 | $246.54 | −$135.6K | −61.4%346 after | |
| Nov 10, 2025 (view filing) | Nov 6 | 4 days | Barry JamesEVP, President, LSG | SSaleBio-Rad A Common Stock | −699.87 | $306.18 | −$214.3K | −57.9%509.68 after | |
| Mar 18, 2025 (view filing) | Mar 14 | 4 days | Crowley MichaelEVP, GBL Commercial Operations | SSaleBio-Rad A Common Stock | −3.00K | $247.06 | −$741.2K | −26.9%8.17K after | |
| Sep 10, 2024 (view filing) | Sep 6 | 4 days | Last Andrew J.EVP, Chief Operating Officer | SSaleBio-Rad A Common Stock | −3.00K | $329.94 | −$989.8K | −28.4%7.56K after | |
| Sep 4, 2024 (view filing) | Sep 4 | Same day | Barry JamesEVP, President, LSG | SSaleBio-Rad A Common Stock | −623 | $330.49 | −$205.9K | −81.0%146.56 after | |
| Jun 14, 2024 (view filing) | Jun 13 | 1 day | Crowley MichaelEVP, GBL Commercial Operations | SSaleBio-Rad A Common Stock | −369 | $281.91 | −$104.0K | −5.3%6.57K after | |
| May 1, 2024 (view filing) | May 3, 2023 | 364 daysLate | Schwartz Steven D10% Owner | SSaleBio-Rad A Common Stock | −320 | $463.86 | −$148.4K | −17.6%1.50K after | |
| Feb 29, 2024 (view filing) | Feb 28 | 1 day | Ernst Timothy SEVP, General Counsel & Sec | SSaleBio-Rad A Common Stock | −2.50K | $330.55 | −$826.4K | −42.4%3.40K after | |
| Feb 28, 2024 (view filing) | Feb 27 | 1 day | Crowley MichaelEVP, GBL Commercial Operations | SSaleBio-Rad A Common Stock | −3.00K | $336.00 | −$1.01M | −30.2%6.94K after | |
| Dec 12, 2023 (view filing) | Dec 12 | Same day | Wright DaraEVP, President, CDG | SSaleBio-Rad A Common Stock | −1.20K | $299.16 | −$359.0K | −44.5%1.50K after | |
| Nov 28, 2023 (view filing) | Nov 28 | Same day | Crowley MichaelEVP, GBL Commercial Operations | SSaleBio-Rad A Common Stock | −642 | $305.10 | −$195.9K | −8.5%6.94K after | |
| Aug 31, 2023 (view filing) | Aug 30 | 1 day | Ernst Timothy SEVP, General Counsel & Sec | SSaleBio-Rad A Common Stock | −2.35K | $395.60 | −$929.7K | −49.3%2.42K after | 3 lots |
| Aug 23, 2023 (view filing) | Aug 23 | Same day | Ernst Timothy SEVP, General Counsel & Sec | SSaleBio-Rad A Common Stock | −300 | $384.69 | −$115.4K | −11.0%2.42K after | |
| Jun 16, 2023 (view filing) | Jun 15 | 1 day | Crowley MichaelEVP, GBL Commercial Operations | SSaleBio-Rad A Common Stock | −500 | $379.39 | −$189.7K | −7.6%6.04K after | |
| Jun 7, 2023 (view filing) | Jun 6 | 1 day | Ramalingam AjitSVP, Chief Accounting Officer | SSaleBio-Rad A Common Stock | −198.35 | $368.30 | −$73.1K | −100.0%0 after | 2 lots |
| Mar 8, 2023 (view filing) | Mar 8 | Same day | Ernst Timothy SEVP, General Counsel & Sec | SSaleBio-Rad A Common Stock | −1.75K | $486.43 | −$849.3K | −39.5%2.67K after | 2 lots |
| Nov 14, 2022 (view filing) | Nov 10 | 4 days | Ramalingam AjitSVP, Chief Accounting Officer | SSaleBio-Rad A Common Stock | −379.38 | $421.87 | −$160.1K | −100.0%0 after | 3 lots |
| Aug 8, 2022 (view filing) | Aug 5 | 3 days | Ramalingam AjitSVP, Chief Accounting Officer | SSaleBio-Rad A Common Stock | −518 | $537.00 | −$278.2K | −84.0%98.5 after | |
| Nov 15, 2021 (view filing) | Nov 11-12 | 4 days | Tumolo AnnetteExecutive Vice President | SSaleBio-Rad A Common Stock | −6.35K | $749.79 | −$4.76M | −58.0%4.59K after | 4 lots |
| Sep 8, 2021 (view filing) | Sep 3 | 5 days | Daskal IlanEVP, Chief Financial Officer | SSaleBio-Rad A Common Stock | −270 | $820.06 | −$221.4K | −96.8%9 after | |
| Sep 3, 2021 (view filing) | Sep 1 | 2 days | Last Andrew J.EVP, Chief Operating Officer | SSaleBio-Rad A Common Stock | −2.00K | $813.10 | −$1.63M | −60.9%1.28K after | 3 lots |
| Sep 3, 2021 (view filing) | Sep 2 | 1 day | Daskal IlanEVP, Chief Financial Officer | SSaleBio-Rad A Common Stock | −540 | $828.00 | −$447.1K | −98.7%7 after | 2 lots |
| Aug 27, 2021 (view filing) | Aug 26 | 1 day | Tumolo AnnetteExecutive Vice President | SSaleBio-Rad A Common Stock | −600 | $792.58 | −$475.5K | −16.2%3.10K after | |
| Aug 10, 2021 (view filing) | Aug 9 | 1 day | Crowley MichaelEVP, GBL Commercial Operations | SSaleBio-Rad A Common Stock | −3.00K | $754.93 | −$2.26M | −45.0%3.67K after | 2 lots |
| Aug 5, 2021 (view filing) | Aug 4 | 1 day | Ernst Timothy SEVP, General Counsel & Sec | SSaleBio-Rad A Common Stock | −327 | $760.26 | −$248.6K | −26.2%919.05 after | |
| Aug 5, 2021 (view filing) | Aug 4 | 1 day | Daskal IlanEVP, Chief Financial Officer | SSaleBio-Rad A Common Stock | −2.30K | $751.84 | −$1.73M | −99.7%7 after | 3 lots |